MicroRNAs and hepatitis C virus: Toward the end of miR-122 supremacy

Virology Journal

Volumn 9, Issue , 2012, Pages

  Hoffmann, Thomas Walter ^a,b   Gilles, Duverlie ^a,b   Abderrahmane, Bengrine ^a,b  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b Centre Hospitalier Universitaire DAmiens   (France)

Author keywords

Hepatitis C virus; MicroRNAs; New therapeutic targets; Virus host interactions

Indexed keywords

ARGONAUTE 2 PROTEIN; GAMMA INTERFERON; HEPATITIS C VACCINE; MICRORNA; MICRORNA 122; MICRORNA 199A; MICRORNA 199A 3P; MICRORNA 199B; MICRORNA 29; MICRORNA 29B; MICRORNA 29C; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENE EXPRESSION; GENOTYPE; HEPATITIS C VIRUS; HOST CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; REVIEW; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MICRORNAS;

CERCOPITHECINE HERPESVIRUS 1; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84861986230     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-109     Document Type: Review

References (70)

1. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621 (Pubitemid 24014542)
2. The nuclear RNase III Drosha initiates microRNA processing. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN, Nature 2003 425 415 419 10.1038/nature01957 14508493 (Pubitemid 37187272)
3. The functions of animal microRNAs. Ambros V, Nature 2004 431 350 355 10.1038/nature02871 15372042 (Pubitemid 39265675)
4. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Yi R, Qin Y, Macara IG, Cullen BR, Genes Dev 2003 17 3011 3016 10.1101/gad.1158803 14681208 (Pubitemid 38040764)
5. Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model. Jalvy-Delvaille S, Maurel M, Majo V, Pierre N, Chabas S, Combe C, Rosenbaum J, Sagliocco F, Grosset CF, Nucleic Acids Res 2012 40 1356 1365 10.1093/nar/gkr843 22009679
6. The microRNA Registry. Griffiths-Jones S, Nucleic Acids Res 2004 32 109 D111 10.1093/nar/gkh023 14681370
7. miRBase: tools for microRNA genomics. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, Nucleic Acids Res 2008 36 154 D158 10.1093/nar/gkn221 17991681
8. miRBase: integrating microRNA annotation and deep-sequencing data. Kozomara A, Griffiths-Jones S, Nucleic Acids Res 2011 39 152 D157 10.1093/nar/gkq1027 21037258
9. Global epidemiology of hepatitis C virus infection. Shepard CW, Finelli L, Alter MJ, Lancet Infect Dis 2005 5 558 567 10.1016/S1473-3099(05)70216-4 16122679 (Pubitemid 41196755)
10. Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? Wu Q, Liu Q, Hepatol Res 2012 in press 10.1111/j.1872-1034X. 2012.00994.x
11. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients. Feuerstadt P, Bunim AL, Garcia H, Karlitz JJ, Massoumi H, Thosani AJ, Pellecchia A, Wolkoff AW, Gaglio PJ, Reinus JF, Hepatology 2009 51 1137 1143
12. An overview of emerging therapies for the treatment of chronic hepatitis C. Ilyas JA, Vierling JM, Clin Liver Dis 2011 15 515 536 10.1016/j.cld.2011.05. 002 21867934
13. New insights into structure and replication of the hepatitis C virus and clinical implications. Poenisch M, Bartenschlager R, Semin Liver Dis 2010 30 333 347 10.1055/s-0030-1267535 20960374
14. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster. Yang X, Haurigot V, Zhou S, Luo G, Couto LB, Hepatology 2010 52 1877 1887 10.1002/hep.23908 20931557
15. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA, Nature 2006 441 537 541 10.1038/nature04791 16724069 (Pubitemid 44050158)
16. Dual regulation of hepatitis C viral RNA by cellular RNAi requires partitioning of Ago2 to lipid droplets and P-bodies. Berezhna SY, Supekova L, Sever MJ, Schultz PG, Deniz AA, RNA 2011 17 1831 1845 10.1261/rna.2523911 21868483
17. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, Science 2005 309 1577 1581 10.1126/science.1113329 16141076 (Pubitemid 41266486)
18. Competing roles of microRNA-122 recognition elements in hepatitis C virus RNA. Nasheri N, Singaravelu R, Goodmurphy M, Lyn RK, Pezacki JP, Virology 2011 410 336 344 10.1016/j.virol.2010.11.015 21185047
19. Liver-specific microRNA-122: Biogenesis and function. Jopling C, RNA Biol 2012 9 137 142 10.4161/rna.18827 22258222
20. Identification of tissue-specific microRNAs from mouse. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T, Curr Biol 2002 12 735 739 10.1016/S0960-9822(02)00809-6 12007417 (Pubitemid 34455427)
21. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM, RNA Biol 2004 1 106 113 10.4161/rna.1.2.1066 17179747
22. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X, Cancer Cell 2011 19 232 243 10.1016/j.ccr.2011.01.001 21316602
23. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H, Science 2010 327 198 201 10.1126/science.1178178 19965718
24. Cellular cofactors affecting hepatitis C virus infection and replication. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM, Proc Natl Acad Sci U S A 2007 104 12884 12889 10.1073/pnas.0704894104 17616579 (Pubitemid 47255249)
25. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP, J Infect Dis 2011 203 1753 1762 10.1093/infdis/jir186 21606534
26. Regulation of the hepatitis C virus genome replication by miR-199a*. Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K, J Hepatol 2009 50 453 460 19144437
27. Interferon modulation of cellular microRNAs as an antiviral mechanism. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M, Nature 2007 449 919 922 10.1038/nature06205 17943132 (Pubitemid 47598616)
28. MicroRNAs and liver disease. Kerr TA, Korenblat KM, Davidson NO, Transl Res 2011 157 241 252 10.1016/j.trsl.2011.01.008 21420035
29. MicroRNA in HCV infection and liver cancer. Kumar A, Biochim Biophys Acta 2011 1809 694 699 10.1016/j.bbagrm.2011.07.010 21821155
30. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Pfeffer S, Baumert TF, Gastroenterol Clin Biol 2010 34 431 435 10.1016/j.gcb.2010.04.010 20537478
31. MicroRNA-196: critical roles and clinical applications in development and cancer. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q, J Cell Mol Med 2011 15 14 23 10.1111/j.1582-4934.2010.01219.x 21091634
32. MicroRNA-directed cleavage of HOXB8 mRNA. Yekta S, Shih IH, Bartel DP, Science 2004 304 594 596 10.1126/science.1097434 15105502 (Pubitemid 38541919)
33. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N, Gastroenterology 2008 135 257 269 10.1053/j.gastro.2008.04.003 18555017 (Pubitemid 351910680)
34. Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G, Riva E, Pizzigallo E, Antonelli G, Virol J 2010 7 311 10.1186/1743-422X-7-311 21070682
35. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hou W, Tian Q, Zheng J, Bonkovsky HL, Hepatology 2010 51 1494 1504 10.1002/hep.23401 20127796
36. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL, Gastroenterology 2007 133 1166 1174 10.1053/j.gastro.2007.08.002 17919492 (Pubitemid 47494462)
37. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T, Clin Cancer Res 2010 16 957 966 10.1158/1078-0432.CCR-09-2123 20103677
38. An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. Bruni R, Marcantonio C, Tritarelli E, Tataseo P, Stellacci E, Costantino A, Villano U, Battistini A, Ciccaglione AR, BMC Genomics 2011 12 485 10.1186/1471-2164-12-485 21970718
39. Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells. Grek M, Piekarska A, Bartkowiak J, Fendler W, Kuydowicz J, Wroblewski P, Paradowski M, Sidorkiewicz M, Int J Mol Med 2011 28 875 880 21750860
40. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L, Cancer Res 2010 70 5184 5193 10.1158/0008-5472.CAN-10-0145 20501828
41. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR, Banerjee S, Schmittgen TD, Biochem Biophys Res Commun 2010 403 120 125 10.1016/j.bbrc.2010.10.130 21055388
42. Lentivirus-Mediated Overexpression of MicroRNA-199a Inhibits Cell Proliferation of Human Hepatocellular Carcinoma. Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ, Cell Biochem Biophys 2012 62 237 244 10.1007/s12013-011-9263-8 21847633
43. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC, J Biol Chem 2008 283 18158 18166 10.1074/jbc.M800186200 18456660
44. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K, PLoS One 2011 6 16081 10.1371/journal.pone.0016081 21283674
45. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo G, Alcohol Clin Exp Res 2009 33 1704 1710 10.1111/j.1530-0277.2009.01007.x 19572984
46. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Santhakumar D, Forster T, Laqtom NN, Fragkoudis R, Dickinson P, Abreu-Goodger C, Manakov SA, Choudhury NR, Griffiths SJ, Vermeulen A, Enright AJ, Dutia B, Kohl A, Ghazal P, Buck AH, Proc Natl Acad Sci U S A 2010 107 13830 13835 10.1073/pnas.1008861107 20643939
47. Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C. Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, Tajima A, Shimotohno K, BMC Med Genomics 2010 3 48 10.1186/1755-8794-3-48 20969775
48. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H, Antiviral Res 2010 88 169 175 10.1016/j.antiviral.2010.08.008 20728471
49. MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Banaudha K, Kaliszewski M, Korolnek T, Florea L, Yeung ML, Jeang KT, Kumar A, Hepatology 2011 53 53 61 10.1002/hep.24016 20967756
50. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, Aicher LD, Proll S, Katze MG, BMC Genomics 2009 10 373 10.1186/1471-2164-10-373 19671175
51. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T, Hepatology 2010 53 209 218 10.1016/j.jhep.2010.02.017 20890893
52. TGF-beta/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY, J Am Soc Nephrol 2011 22 1462 1474 10.1681/ASN.2010121308 21784902
53. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN, Proc Natl Acad Sci U S A 2008 105 13027 13032 10.1073/pnas.0805038105 18723672
54. miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lu J, Am J Respir Cell Mol Biol 2011 45 287 294 10.1165/rcmb.2010-0323OC 20971881
55. MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-gamma Production in Helper T Cells. Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD, Matloubian M, Blelloch R, Ansel KM, Immunity 2011 35 169 181 10.1016/j.immuni.2011.07.009 21820330
56. MicroRNA 29b functions in acute myeloid leukemia. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM, Blood 2009 114 5331 5341 10.1182/blood-2009-03- 211938 19850741
57. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, Jia JH, Biochem Biophys Res Commun 2011 411 586 592 10.1016/j.bbrc.2011.06.191 21763284
58. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM, Hepatology 2010 51 836 845 20041405
59. Epigenetic Changes Mediated by MicroRNA miR29 Activate Cyclooxygenase 2 and Lambda-1 Interferon Production during Viral Infection. Fang J, Hao Q, Liu L, Li Y, Wu J, Huo X, Zhu Y, J Virol 2012 86 1010 1020 10.1128/JVI.06169-11 22072783
60. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Liu X, Wang T, Wakita T, Yang W, Virology 2010 398 57 67 10.1016/j.virol.2009.11.036 20006370
61. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S, Hepatology 2009 49 1098 1112 10.1002/hep.22749 19173277
62. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M, Hepatology 2008 47 1223 1232 18307259 (Pubitemid 351547908)
63. Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T, Biochem Biophys Res Commun 2011 412 92 97 10.1016/j.bbrc.2011.07.049 21802413
64. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T, Int J Cancer 2010 127 1072 1080 20039318
65. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus. Steuerwald NM, Parsons JC, Bennett K, Bates TC, Bonkovsky HL, Liver Int 2010 30 1490 1504 10.1111/j.1478-3231.2010. 02321.x 20825557
66. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, Einav U, Gilad S, Hurban P, Karov Y, Lobenhofer EK, Sharon E, Shiboleth YM, Shtutman M, Bentwich Z, Einat P, Genome Res 2004 14 2486 2494 10.1101/gr.2845604 15574827 (Pubitemid 40012232)
67. A simple array platform for microRNA analysis and its application in mouse tissues. Tang X, Gal J, Zhuang X, Wang W, Zhu H, Tang G, RNA 2007 13 1803 1822 10.1261/rna.498607 17675362 (Pubitemid 47481688)
68. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP, Am J Physiol Gastrointest Liver Physiol 2010 298 535 G541 10.1152/ajpgi.00338.2009 20167875
69. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T, Gastroenterology 2007 133 647 658 10.1053/j.gastro.2007.05.022 17681183 (Pubitemid 47187346)
70. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP, Lab Invest 2010 90 1727 1736 10.1038/labinvest.2010. 126 20625373